Triamcinolone Completed Phase 3 Trials for Vitrectomy therapy Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00532415Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy